These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 17220332)

  • 21. IGF-I and mammographic density in four geographic locations: a pooled analysis.
    Maskarinec G; Takata Y; Chen Z; Gram IT; Nagata C; Pagano I; Hayashi K; Arendell L; Skeie G; Rinaldi S; Kaaks R
    Int J Cancer; 2007 Oct; 121(8):1786-92. PubMed ID: 17520679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women.
    dos Santos Silva I; Johnson N; De Stavola B; Torres-Mejía G; Fletcher O; Allen DS; Allen NE; Key TJ; Fentiman IS; Holly JM; Peto J
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):449-55. PubMed ID: 16537700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-like growth factor-I (IGF-1), IGF-binding protein-3 (IGFBP-3) and mammographic features.
    Izzo L; Meggiorini ML; Nofroni I; Pala A; De Felice C; Meloni P; Simari T; Izzo S; Pugliese F; Impara L; Merlini G; Di Cello P; Cipolla V; Forcione AR; Paliotta A; Domenici L; Bolognese A
    G Chir; 2012 May; 33(5):153-62. PubMed ID: 22709450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.
    Diorio C; Brisson J; Bérubé S; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):880-8. PubMed ID: 18398029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal changes in IGF-I and IGFBP-3, and mammographic density among postmenopausal women.
    Woolcott CG; Courneya KS; Boyd NF; Yaffe MJ; McTiernan A; Brant R; Jones CA; Stanczyk FZ; Terry T; Cook LS; Wang Q; Friedenreich CM
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2116-20. PubMed ID: 24019394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer.
    Rollison DE; Newschaffer CJ; Tao Y; Pollak M; Helzlsouer KJ
    Int J Cancer; 2006 Mar; 118(5):1279-84. PubMed ID: 16161053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status.
    Barnes BB; Chang-Claude J; Flesch-Janys D; Kinscherf R; Schmidt M; Slanger T; Bonaterra G; Steindorf K
    Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The vitamin D pathway and mammographic breast density among postmenopausal women.
    Sprague BL; Trentham-Dietz A; Gangnon RE; Buist DS; Burnside ES; Aiello Bowles EJ; Stanczyk FZ; Sisney GS; Skinner HG
    Breast Cancer Res Treat; 2012 Jan; 131(1):255-65. PubMed ID: 21847642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
    Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV
    Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer.
    Keinan-Boker L; Bueno De Mesquita HB; Kaaks R; Van Gils CH; Van Noord PA; Rinaldi S; Riboli E; Seidell JC; Grobbee DE; Peeters PH
    Int J Cancer; 2003 Aug; 106(1):90-5. PubMed ID: 12794762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of circulating insulin-like growth factor-I and binding proteins 1-7 with mammographic density among women undergoing image-guided diagnostic breast biopsy.
    Hada M; Oh H; Pfeiffer RM; Falk RT; Fan S; Mullooly M; Pollak M; Geller B; Vacek PM; Weaver D; Shepherd J; Wang J; Fan B; Mahmoudzadeh AP; Malkov S; Herschorn S; Brinton LA; Sherman ME; Gierach GL
    Breast Cancer Res; 2019 Jul; 21(1):81. PubMed ID: 31337427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone therapy use and mammographic density in postmenopausal Norwegian women.
    Couto E; Qureshi SA; Hofvind S; Hilsen M; Aase H; Skaane P; Vatten L; Ursin G
    Breast Cancer Res Treat; 2012 Feb; 132(1):297-305. PubMed ID: 22052325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal and perinatal correlates of adult mammographic breast density.
    Cerhan JR; Sellers TA; Janney CA; Pankratz VS; Brandt KR; Vachon CM
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1502-8. PubMed ID: 15941963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of long-term treatment with raloxifene on mammary density in postmenopausal women.
    Lasco A; Gaudio A; Morini E; Morabito N; Nicita-Mauro C; Catalano A; Denuzzo G; Sansotta C; Xourafa A; Macrì I; Frisina N
    Menopause; 2006; 13(5):787-92. PubMed ID: 16912660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
    Tamimi RM; Byrne C; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway.
    Vatten LJ; Holly JM; Gunnell D; Tretli S
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2097-100. PubMed ID: 18708402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association of breast mitogens with mammographic densities.
    Boyd NF; Stone J; Martin LJ; Jong R; Fishell E; Yaffe M; Hammond G; Minkin S
    Br J Cancer; 2002 Oct; 87(8):876-82. PubMed ID: 12373602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women.
    Stuedal A; Ma H; Bjørndal H; Ursin G
    Climacteric; 2009 Jun; 12(3):248-58. PubMed ID: 19387884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-like growth factor-I and mammographic breast density.
    Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):3019; author reply 3019. PubMed ID: 16365031
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.